Free Trial

Augmedix (AUGX) Competitors

$2.35
0.00 (0.00%)
(As of 10/2/2024)

AUGX vs. PRTH, ABSI, GRVY, BWMN, TIXT, MXCT, IBEX, ACCD, OOMA, and SHAP

Should you be buying Augmedix stock or one of its competitors? The main competitors of Augmedix include Priority Technology (PRTH), Absci (ABSI), Gravity (GRVY), Bowman Consulting Group (BWMN), TELUS International (Cda) (TIXT), MaxCyte (MXCT), IBEX (IBEX), Accolade (ACCD), Ooma (OOMA), and Spree Acquisition Corp. 1 (SHAP). These companies are all part of the "business services" industry.

Augmedix vs.

Priority Technology (NASDAQ:PRTH) and Augmedix (NASDAQ:AUGX) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, community ranking, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

Priority Technology currently has a consensus target price of $9.00, indicating a potential upside of 40.85%. Augmedix has a consensus target price of $3.09, indicating a potential upside of 31.38%. Given Priority Technology's stronger consensus rating and higher probable upside, analysts clearly believe Priority Technology is more favorable than Augmedix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Priority Technology
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Augmedix
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Priority Technology received 20 more outperform votes than Augmedix when rated by MarketBeat users. Likewise, 48.00% of users gave Priority Technology an outperform vote while only 36.36% of users gave Augmedix an outperform vote.

CompanyUnderperformOutperform
Priority TechnologyOutperform Votes
24
48.00%
Underperform Votes
26
52.00%
AugmedixOutperform Votes
4
36.36%
Underperform Votes
7
63.64%

Priority Technology has higher revenue and earnings than Augmedix. Priority Technology is trading at a lower price-to-earnings ratio than Augmedix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Priority Technology$755.61M0.66-$1.31M-$0.58-11.12
Augmedix$51.58M2.23-$19.17M-$0.43-5.47

11.5% of Priority Technology shares are owned by institutional investors. Comparatively, 87.1% of Augmedix shares are owned by institutional investors. 76.3% of Priority Technology shares are owned by insiders. Comparatively, 11.0% of Augmedix shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Priority Technology had 3 more articles in the media than Augmedix. MarketBeat recorded 4 mentions for Priority Technology and 1 mentions for Augmedix. Augmedix's average media sentiment score of 0.90 beat Priority Technology's score of 0.21 indicating that Augmedix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Priority Technology
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Augmedix
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Priority Technology has a net margin of 0.74% compared to Augmedix's net margin of -46.23%. Priority Technology's return on equity of -9.60% beat Augmedix's return on equity.

Company Net Margins Return on Equity Return on Assets
Priority Technology0.74% -9.60% 0.90%
Augmedix -46.23%-182.36%-43.21%

Priority Technology has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, Augmedix has a beta of -0.22, meaning that its stock price is 122% less volatile than the S&P 500.

Summary

Priority Technology beats Augmedix on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AUGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AUGX vs. The Competition

MetricAugmedixBusiness services IndustryMedical SectorNASDAQ Exchange
Market Cap$115.08M$20.41B$5.36B$8.45B
Dividend YieldN/A2.41%4.68%4.13%
P/E Ratio-5.4644.37136.6318.48
Price / Sales2.236.591,185.5071.15
Price / CashN/A25.7837.8233.24
Price / Book4.205.384.794.83
Net Income-$19.17M$507.52M$113.95M$224.95M
7 Day PerformanceN/A12.67%1.23%2.56%
1 Month Performance0.86%25.74%14.37%11.89%
1 Year Performance-55.66%23.01%23.87%20.09%

Augmedix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AUGX
Augmedix
3.0684 of 5 stars
$2.35
flat
$3.09
+31.4%
N/A$115.08M$51.58M-5.461,430News Coverage
PRTH
Priority Technology
4.2395 of 5 stars
$6.30
+4.5%
$9.00
+42.9%
+86.6%$453.31M$755.61M-10.86790Gap Up
ABSI
Absci
1.9583 of 5 stars
$3.88
+1.8%
$8.67
+123.4%
+185.5%$438.77M$3.25M-3.34210Gap Up
GRVY
Gravity
1.0266 of 5 stars
$61.50
+3.5%
N/A-8.8%$427.36M$564.42B4.65340High Trading Volume
BWMN
Bowman Consulting Group
3.438 of 5 stars
$23.54
0.0%
$40.10
+70.3%
-20.9%$415.88M$386.81M-35.132,000
TIXT
TELUS International (Cda)
4.0338 of 5 stars
$3.75
+1.6%
$7.55
+101.4%
-51.3%$400.61M$2.71B25.0075,347Positive News
MXCT
MaxCyte
3.1207 of 5 stars
$3.67
+1.4%
$8.67
+136.1%
+35.7%$384.70M$45.44M-10.4980Gap Up
IBEX
IBEX
1.9652 of 5 stars
$19.29
+1.2%
$20.50
+6.3%
+22.7%$332.06M$508.57M12.6130,000
ACCD
Accolade
4.7689 of 5 stars
$3.75
+1.9%
$10.68
+184.8%
-50.7%$300.03M$431.53M-3.232,400Earnings Report
Analyst Forecast
News Coverage
OOMA
Ooma
2.5376 of 5 stars
$11.23
+0.7%
$14.50
+29.1%
-11.4%$296.47M$248.16M-112.301,221
SHAP
Spree Acquisition Corp. 1
N/A$10.91
flat
N/AN/A$283.07MN/A0.00N/APositive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:AUGX) was last updated on 10/9/2024 by MarketBeat.com Staff
From Our Partners